Partnership with Diagnostics lab

Chemical, Biological, Radiological, Nuclear, and high yield Explosives (CBRNE) Emergency Management Subject Matter Expert (SME) in support of Diagnostics Lab in Columbia, Maryland business development and product development support activities for medical countermeasures. Current work efforts include infectious disease point-of-care diagnostic device development, FDA 510K approvals, training and marketplace planning for Plague and COVID-19 for civilian and military end users via Medical Technology Enterprise Consortium, Medical CBRN Defense Consortium, Countering Weapons of Mass Destruction (CWMD) Consortium, and directly with the Department of Defense and international agencies, universities, and laboratories (e.g., Defense Threat Reduction Agency (DTRA), U.S. Army Combat Capabilities Development Command Chemical Biological Center, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Singapore National University, Northern Arizona University).